Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 208

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Characterization of IgG4 anti‐neurofascin 155 antibody‐positive polyneuropathy

Open access
Ogata, Hidenori, Yamasaki, Ryo, Hiwatashi, Akio, Oka, Nobuyuki, Kawamura, Nobutoshi, Matsuse, Dai, Kuwahara, Motoi, Suzuki, Hidekazu, Kusunoki, Susumu, Fujimoto, Yuichi, Ikezoe, Koji, Kishida, Hitaru, Tanaka, Fumiaki, Matsushita, Takuya, Murai, Hiroyuki, Kira, Jun‐ichi·2015·Annals of Clinical and Translational Neurology

Abstract

Objective: To investigate anti‐neurofascin 155 (NF 155) antibody‐positive chronic inflammatory demyelinating polyneuropathy (CIDP). Methods: Sera from 50 consecutive CIDP patients diagnosed in our clinic, 32 patients with multiple sclerosis, 40 patients with other neuropathies including 26 with Guillain–Barré syndrome (GBS)/Fisher syndrome, and 30 healthy controls were measured for anti‐NF antibodies by flow cytometry using HEK 293 cell lines stably expressing human NF 155 or NF 186. Four additional CIDP patients with anti‐NF 155 antibodies referred from other clinics were enrolled for clinical characterization. Results: The positivity rate for anti‐NF 155 antibodies in CIDP patients was 18% (9/50), who all showed a predominance of IgG4 subclass. No other subjects were positive, except one GBS patient harboring IgG1 anti‐NF 155 antibodies. No anti‐NF 155 antibody carriers had anti‐NF 186 antibodies. Anti‐NF 155 antibody‐positive CIDP patients had a significantly younger onset age, higher frequency of drop foot, gait disturbance, tremor and distal acquired demyelinating symmetric phenotype, greater cervical root diameter on magnetic resonance imaging neurography, higher cerebrospinal fluid protein levels, and longer distal and F‐wave latencies than anti‐NF 155 antibody‐negative patients. Marked symmetric hypertrophy of cervical and lumbosacral roots/plexuses was present in all anti‐NF 155 antibody‐positive CIDP patients examined by neurography. Biopsied sural nerves from two patients with anti‐NF 155 antibodies demonstrated subperineurial edema and occasional paranodal demyelination, but no vasculitis, inflammatory cell infiltrates, or onion bulbs. Among anti‐NF 155 antibody‐positive patients, treatment responders more frequently had daily oral corticosteroids and/or immunosuppressants in addition to intravenous immunoglobulins than nonresponders did. Interpretation: Anti‐NF 155 antibodies occur in a subset of CIDP patients with distal‐dominant involvement and symmetric nerve hypertrophy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acn3.248

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 208

Metadata

Authors
Ogata, H., Yamasaki, R., Hiwatashi, A., Oka, N., Kawamura, N., Matsuse, D., Kuwahara, M., Suzuki, H., Kusunoki, S., Fujimoto, Y., Ikezoe, K., Kishida, H., Tanaka, F., Matsushita, T., Murai, H., & Kira, J.
Venue
Annals of Clinical and Translational Neurology
Publisher
Wiley
Published
2015-09-11
Volume
2
Issue
10
Pages
960-971
ISSN
2328-9503 (ISSN-L)
OpenAlex
W2139284610
Cited by
208
References
1
FWCI
8.71
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of IgG4 anti‐neurofascin 155 antibody‐positive polyneuropathy. https://app.cochat.ai/papers/10.1002/acn3.248
The paper
Ogata, H., Yamasaki, R., Hiwatashi, A., Oka, N., Kawamura, N., Matsuse, D., Kuwahara, M., Suzuki, H., Kusunoki, S., Fujimoto, Y., Ikezoe, K., Kishida, H., Tanaka, F., Matsushita, T., Murai, H., & Kira, J. (2015). Characterization of IgG4 anti‐neurofascin 155 antibody‐positive polyneuropathy. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.248

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.